Discontinued — last reported Q4 '25

Business Segments · Goodwill

Health & Science Technologies — Goodwill

IDEX Health & Science Technologies — Goodwill increased by 5.7% to $2.41B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $2.28B to $2.41B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025Apr 29, 2026
Rolls up toGoodwill

How to read this metric

High goodwill levels indicate significant historical acquisition activity within the segment.

Detailed definition

The premium paid over the fair value of net identifiable assets when acquiring businesses that are integrated into the H...

Peer comparison

Standard accounting metric for segments that have grown through acquisitions, common in diversified industrial firms.

Metric ID: iex_segment_health_science_technologies_goodwill

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.26B$1.64B$1.83B$2.28B$2.41B
QoQ Change+30.1%+11.5%+24.1%+5.7%
YoY Change+30.1%+11.5%+24.1%+5.7%
Range$1.26B$2.41B
CAGR+90.3%
Avg YoY Growth+17.9%
Median YoY Growth+17.8%
Current Streak4+ quarters growth

Frequently Asked Questions

What is IDEX's health & science technologies — goodwill?
IDEX (IEX) reported health & science technologies — goodwill of $2.41B in Q4 2025.
How has IDEX's health & science technologies — goodwill changed year-over-year?
IDEX's health & science technologies — goodwill increased by 5.7% year-over-year, from $2.28B to $2.41B.
What does health & science technologies — goodwill mean?
The excess purchase price paid for acquisitions within the Health and Science Technologies segment.